Comments*

 
  • Academy Events

  • Malaria 2014: Advances in Pathophysiology, Biology and Drug Development

    Friday, April 25, 2014 | 8:00 AM - 5:30 PM
    The New York Academy of Sciences

    Presented by the Microbiology & Infectious Diseases Discussion Group

    Related Content

    With approximately 3.3 billion people (one half of the world’s population) still at risk of contracting malaria, and over 650,000 malaria deaths annually, there is still much work to be done before this disease can be controlled and possibly eradicated. Increased prevention and control measures have led to a 25% worldwide reduction in malaria mortality rates since 2000. However, those living in the poorest countries remain the most vulnerable to malaria, and nearly 90% of all malaria deaths worldwide occur in the sub-Saharan Africa, mostly among children under five years of age infected with the malaria parasite Plasmodium falciparum. This one-day symposium examines the latest developments in understanding disease processes and the biology of the parasite, and developing antimalarial drugs and candidate vaccines. We will present recent research findings including the pathophysiology and neuropathology of cerebral malaria, the molecular mechanisms of sporozoite invasion in the liver, and the development of novel antimalarial therapies. We will also explore drug resistance to the artemisinin derivatives that are the core components of current drug combination therapies. Join us and our outstanding panel of speakers on World Malaria Day for a very exciting symposium.

    Reception to follow.

    Registration and Webinar Pricing

    Member $30
    Student/Postdoc Member $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Resident / Fellow) $45

     


    The Microbiology & Infectious Diseases Discussion Group is proudly supported by

     


    Mission Partner support for the Frontiers of Science program provided by Pfizer

    EmailPrint